POSTER 10

Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months in Patients with Alopecia Areata (AA) from the ALLEGRO Clinical Trial Program

Maryanne Senna, Sameh Hanna, Rie Ueki, Xingqi Zhang, Crystal Aguh, Bianca Maria Piraccini, Edward Nagy, Alexandre Lejeune, Mojgan Sadrarhami, Simon Chen, Robert Wolk

< Previous Poster | Next Poster >

Poster 10